Insider Transactions in Q1 2022 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2022
|
Elizabeth A. Barrett Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,195
-1.32%
|
$57,365
$7.58 P/Share
|
|
Jan 31
2022
|
Elizabeth A. Barrett Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,333
+2.85%
|
-
|
|
Jan 31
2022
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,374
-2.87%
|
$9,618
$7.58 P/Share
|
|
Jan 31
2022
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+4.88%
|
-
|
|
Jan 31
2022
|
Molly Henderson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
331
-5.93%
|
$2,317
$7.58 P/Share
|
|
Jan 31
2022
|
Molly Henderson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
666
+10.66%
|
-
|
|
Jan 31
2022
|
Jason Drew Smith General Counsel |
SELL
Open market or private sale
|
Direct |
414
-5.27%
|
$2,898
$7.58 P/Share
|
|
Jan 31
2022
|
Jason Drew Smith General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
833
+9.58%
|
-
|
|
Jan 26
2022
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
111
-0.5%
|
$888
$8.09 P/Share
|
|
Jan 26
2022
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209
+0.93%
|
-
|
|
Jan 04
2022
|
Elizabeth A. Barrett Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
46,968
-13.61%
|
$422,712
$9.15 P/Share
|
|
Jan 03
2022
|
Elizabeth A. Barrett Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
105,689
+23.44%
|
-
|